Medical Excellence Groups | Maturity, Drivers & Benefits

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Building an Elite Medical Excellence Group: Maturity, Drivers, and Benefits”

STUDY OVERVIEW

As novel tools and technologies have transformed the biopharma engagement model and unlocked new opportunity areas for Medical Affairs, the need for specialized Medical Excellence groups has never been greater.

While several leading organizations have already established a dedicated Medical Excellence group, many are planning to establish one in the near term.

Best Practices, LLC undertook benchmarking research to identify the drivers and benefits of Medical Excellence group creation.

The study also looks at the maturity and tenure of Medical Excellence groups. Additionally, it includes benchmark data from organizations planning to establish a Medical Excellence group in the near future.

Data in this study are further segmented by company size – Large companies vs. Small & Mid-size companies.

KEY TOPICS

Medical Excellence Group Implementation Status and Tenure
Benefits of Medical Excellence Groups
Main Drivers for Medical Excellence Group Creation
Benchmarks for Proposed Medical Excellence Group

KEY METRICS

Do benchmark companies have a Medical Affairs Excellence group?
How long have benchmark companies had a Medical Affairs Excellence group?
Which Medical Affairs groups does the Excellence group support?
What were the main drivers that led benchmark organizations to create an Excellence group?
How long will it be until the launch of proposed Medical Affairs Excellence groups?
Which Medical Affairs groups do benchmark organizations plan to support with the proposed Excellence groups?
What were the main drivers that led benchmark companies to begin planning an Excellence group?

SAMPLE KEY FINDINGS

Top groups served include Field Medical and Training: The most common internal teams supported by Medical Excellence include Field Medical (served by 88% of surveyed Medical Excellence groups), Training (82%), Strategy (67%), Med Ops (67%) and Thought Leader Management (58%).

METHODOLOGY

Best Practices, LLC engaged 57 leaders from 42 companies in this research though a benchmarking survey instrument and roundtable sessions.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Service; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Amgen; Apellis Pharmaceuticals; Astellas; AstraZeneca; Baxter International; Bayer; Biogen; Boehringer Ingelheim; B. Braun; Cara Therapeutics; Chiesi; Cipla; Daiichi Sankyo; Eisai; Eli Lilly; EVERSANA; Fidia; GE Healthcare; Gilead Sciences; GlaxoSmithKline ; Heron Therapeutics; Ipsen; Jazz Pharmaceuticals; Kyowa Kirin; Lupin; Lundbeck; Medexus Pharmaceuticals; Merck; Novartis; Novo Nordisk; Orchard Therapeutics; Pixacore; Provention Bio; Radius Health; Inc.; Roche; Sandoz; Sanofi; Santen; Supernus; Takeda Pharmaceuticals; Taysha Gene Therapies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Building an Elite Medical Excellence Group: Maturity, Drivers, and Benefits

ID: 5735

Features:

Pages/Slides: 30

Published: 2022

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67EE95459D49E0B4E002588AE0046593F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-building-an-elite-medical-excellence-group-maturity-drivers-benefits?OpenDocument
18
19OpenDocument
2018.207.255.67
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB